Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society.
Hyung-Suk KimJong Uk LeeTae-Kyung Robyn YooByung Joo ChaeDonghee SonYun Jin KimWoo Chan ParkPublished in: Journal of breast cancer (2019)
Our large retrospective analysis revealed that adjuvant chemotherapy provided little benefit to improve the prognosis of most ER-positive MBC patients. Therefore, chemotherapy can be omitted in the treatment of most ER-positive MBC.